Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline.
Grassi L, Caruso R, Riba MB, Lloyd-Williams M, Kissane D, Rodin G, McFarland D, Campos-Ródenas R, Zachariae R, Santini D, Ripamonti CI; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Grassi L, et al. Among authors: ripamonti ci. ESMO Open. 2023 Apr;8(2):101155. doi: 10.1016/j.esmoop.2023.101155. Epub 2023 Mar 14. ESMO Open. 2023. PMID: 37087199 Free PMC article.
Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline.
Stone P, Buckle P, Dolan R, Feliu J, Hui D, Laird BJA, Maltoni M, Moine S, Morita T, Nabal M, Vickerstaff V, White N, Santini D, Ripamonti CI; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Stone P, et al. Among authors: ripamonti ci. ESMO Open. 2023 Apr;8(2):101195. doi: 10.1016/j.esmoop.2023.101195. Epub 2023 Apr 11. ESMO Open. 2023. PMID: 37087198 Free PMC article.
'Old' and 'new' drugs for the treatment of cancer pain.
Santini D, Lanzetta G, Dell'Aquila E, Vincenzi B, Venditti O, Russano M, Papapietro N, Denaro V, Tonini G, Ripamonti C. Santini D, et al. Expert Opin Pharmacother. 2013 Mar;14(4):425-33. doi: 10.1517/14656566.2013.774375. Expert Opin Pharmacother. 2013. PMID: 23438421 Review.
Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial.
Amadori D, Aglietta M, Alessi B, Gianni L, Ibrahim T, Farina G, Gaion F, Bertoldo F, Santini D, Rondena R, Bogani P, Ripamonti CI. Amadori D, et al. Among authors: ripamonti ci. Lancet Oncol. 2013 Jun;14(7):663-70. doi: 10.1016/S1470-2045(13)70174-8. Epub 2013 May 16. Lancet Oncol. 2013. PMID: 23684411 Clinical Trial.
Targeting bone metastatic cancer: Role of the mTOR pathway.
Bertoldo F, Silvestris F, Ibrahim T, Cognetti F, Generali D, Ripamonti CI, Amadori D, Colleoni MA, Conte P, Del Mastro L, De Placido S, Ortega C, Santini D. Bertoldo F, et al. Among authors: ripamonti ci. Biochim Biophys Acta. 2014 Apr;1845(2):248-54. doi: 10.1016/j.bbcan.2014.01.009. Epub 2014 Feb 5. Biochim Biophys Acta. 2014. PMID: 24508774 Review.
115 results